Pharmacies - Niger

  • Niger
  • The revenue in the Pharmacies market in Niger is forecasted to reach US$197.70m in 2024.
  • It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 4.65%, leading to a market volume of US$248.10m by 2029.
  • Among all countries, United States is projected to generate the highest revenue in the Pharmacies market, amounting to US$387.30bn in 2024.
  • When considering the total population, the per person revenues in Niger are estimated to be US$7.00 in 2024.
  • Despite facing challenges such as limited access to healthcare, Niger has seen a growing trend of pharmacies expanding their services to reach remote areas.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacies market in Niger has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this development. Customer preferences play a crucial role in the growth of the Pharmacies market in Niger. Consumers in Niger are increasingly seeking convenience and accessibility when it comes to healthcare services. Pharmacies provide a one-stop solution for various healthcare needs, including prescription medications, over-the-counter drugs, and health consultations. This convenience factor has led to an increased demand for pharmacies in Niger. Trends in the market further support the growth of the Pharmacies market in Niger. The healthcare sector in the country has been witnessing advancements and improvements, leading to better access to healthcare services. This has resulted in an increased demand for pharmacies as people seek reliable sources for their healthcare needs. Additionally, the rising prevalence of chronic diseases and the aging population have also contributed to the growth of the Pharmacies market in Niger, as these factors drive the need for regular medication and healthcare products. Local special circumstances also play a role in the development of the Pharmacies market in Niger. The country has a relatively low doctor-to-patient ratio, which means that pharmacies often serve as the first point of contact for healthcare advice and treatment. This reliance on pharmacies for primary healthcare needs has further fueled the growth of the market. Additionally, the government of Niger has been taking steps to improve the healthcare infrastructure in the country, including the expansion of healthcare facilities and the promotion of access to essential medicines. These initiatives have created a favorable environment for the growth of the Pharmacies market. Underlying macroeconomic factors have also contributed to the development of the Pharmacies market in Niger. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income and improved living standards. As a result, people are more willing to spend on healthcare products and services, including medications from pharmacies. Furthermore, the government has implemented policies to promote the pharmaceutical sector, such as the reduction of import duties on pharmaceutical products. These measures have attracted investment in the sector and have further stimulated the growth of the Pharmacies market in Niger. In conclusion, the Pharmacies market in Niger is experiencing significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The convenience provided by pharmacies, advancements in the healthcare sector, reliance on pharmacies for primary healthcare needs, and favorable government initiatives have all contributed to the development of the market. With the continued focus on improving healthcare infrastructure and the increasing demand for healthcare services, the Pharmacies market in Niger is expected to continue its growth trajectory in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Users
  • Volume
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)